• 1 Year Returns: 9.08%
• 3 Year Returns: 22.10%

• Pharmaceuticals | 71.33%
• Labs & Life Sciences Services | 19.14%
• Others | 2.41%
• Plastic Products | 1.47%
• Oil & Gas - Refining & Marketing | 1.30%

• Sun Pharmaceutical Industries Ltd | 14.25%
• Divi's Laboratories Ltd | 8.43%
• Apollo Hospitals Enterprise Ltd | 6.20%
• Laurus Labs Ltd | 5.06%
• Torrent Pharmaceuticals Ltd | 4.90%

• Equity | 98.01%
• Cash & Equivalents | 1.99%

The alpha ratio for the ITI Pharma & Healthcare Fund is -1.68

Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.

The volatility or standard deviation for the ITI Pharma & Healthcare Fund is 13.34

Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.

The Sharpe ratio for the ITI Pharma & Healthcare Fund is 0.34

The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.

The Sortino Ratio for the ITI Pharma & Healthcare Fund is 0.04

The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.